Ameriprise’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.1M Buy
1,995,116
+873,727
+78% +$31.4M 0.02% 675
2026
Q1
$36M Buy
1,121,389
+857
+0.1% +$31.5K 0.01% 1044
2025
Q4
$43M Sell
1,120,532
-230,019
-17% -$5.05M 0.01% 960
2025
Q3
$18.5M Buy
1,350,551
+220,939
+20% +$2.59M ﹤0.01% 1453
2025
Q2
$14.6M Buy
1,129,612
+617,124
+120% +$6.42M ﹤0.01% 1541
2025
Q1
$5.76M Buy
512,488
+418,492
+445% +$5.49M ﹤0.01% 2207
2024
Q4
$1.23M Sell
93,996
-1,176,829
-93% -$30.2M ﹤0.01% 3154
2024
Q3
$50.8M Buy
1,270,825
+384,958
+43% +$14M 0.01% 840
2024
Q2
$26.1M Buy
+885,867
New +$24.1M 0.01% 1117

Other funds holding PACS

Ameriprise's PACS Position: Q2 2026 in Review

Ameriprise increased its PACS Group (PACS) stake by 78% in Q2 2026, buying an estimated $31.4M and bringing the position to 1,995,116 shares worth $85.1M. The position accounts for 0.02% of the portfolio, ranked #675.

Ameriprise first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Ameriprise held 1,995,116 shares of PACS Group worth $85.1M as of Q2 2026.
  • Ameriprise bought 873,727 PACS Group shares in Q2 2026, an estimated $31.4M.
  • PACS Group made up 0.02% of Ameriprise's portfolio in Q2 2026, its #675 holding.
  • Ameriprise first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.